---
schema_version: "secwatch.filing_event.v1"
accession: "0001689548-26-000005"
form_type: "8-K"
ticker: "PRAX"
cik: "0001689548"
company_name: "Praxis Precision Medicines, Inc."
filed_at: "2026-01-08T23:59:59+00:00"
generated_at: "2026-05-16T11:13:22.687897+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Praxis promotes Sniecinski to COO; adds Kindler and Arbuckle to board

## Summary
- Megan Sniecinski promoted to COO effective Jan 1, 2026; previously CBO since Dec 2021.
- Sniecinski's base salary increased to $626,000, target bonus 50% of salary for 2026.
- Jeffrey B. Kindler elected to Board as Class II director, effective Jan 8, 2026; deemed independent.
- Stuart A. Arbuckle elected to Board as Class II director, effective Jan 8, 2026; deemed independent.
- Kindler and Arbuckle entitled to initial stock option awards and annual retainers per company policy.

## SEC filing metadata
- accession: 0001689548-26-000005
- form_type: 8-K
- ticker: PRAX
- cik: 0001689548
- company_name: Praxis Precision Medicines, Inc.
- filed_at: 2026-01-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1689548/000168954826000005/0001689548-26-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1689548/000168954826000005/prax-20260108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001689548-26-000005
- JSON: https://secwatch.observer/filing/0001689548-26-000005.json
- Plain text: https://secwatch.observer/filing/0001689548-26-000005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.